DSM-FIRMENICH AG Inactive Instrument
DSM-Firmenich AG Share Price Wiener Boerse
Equities
RDSM
NL0000009827
Consumer Goods Conglomerates
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 12.63B 13.57B 1,133B | Sales 2025 * | 13.3B 14.29B 1,193B | Capitalization | 28.48B 30.6B 2,554B |
|---|---|---|---|---|---|
| Net income 2024 * | 452M 486M 40.53B | Net income 2025 * | 781M 839M 70.03B | EV / Sales 2024 * | 2.48 x |
| Net Debt 2024 * | 2.85B 3.06B 255B | Net Debt 2025 * | 2.58B 2.77B 232B | EV / Sales 2025 * | 2.34 x |
| P/E ratio 2024 * |
60.8
x | P/E ratio 2025 * |
35.2
x | Employees | 28,685 |
| Yield 2024 * |
2.37% | Yield 2025 * |
2.34% | Free-Float | 25.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on DSM-Firmenich AG
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 01/90/01 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 01/23/01 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 01/23/01 | |
Thomas Leysen
CHM | Chairman | 63 | 01/23/01 |
| Director/Board Member | 62 | 01/23/01 |
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Sector
Consumer Goods Conglomerates
Calendar
03/06/2024
- Capital Markets Day
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| +1.38% | 239B | |
| +32.43% | 185B | |
| -5.53% | 128B | |
| +39.58% | 88B | |
| -5.47% | 73.75B | |
| -11.98% | 52.87B | |
| +40.90% | 38.61B | |
| -25.53% | 38.11B | |
| +61.08% | 31.15B |
